Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply
Academic Article
Publication Date:
2018
Short description:
Editorial: to facitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors' reply / Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - 47:4(2018), pp. 540-541. [10.1111/apt.14486]
Iris type:
1.1 Articolo in rivista
List of contributors:
Bonovas, S; Lytras, T; Nikolopoulos, G; Peyrin-Biroulet, L; Danese, S
Published in: